Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed about submission of disclosures of related party transactions for the half year ended 30th September, 2019. The financial results for the quarter and half year ended 30th September, 2019 both standalone and consolidated were published on 12th November, 2019.
The above information is a part of company’s filings submitted to BSE.